NCT05570253 2026-04-17
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Memorial Sloan Kettering Cancer Center
Sun Yat-sen University
OHSU Knight Cancer Institute
MedSIR